← Leaderboards
Manisha Shah
Ohio State University
$775,581
Attributed
$985,803
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $420.4K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$985,803 · 3
By mechanism
R01$420,445 · 1
R21$399,775 · 1
U01$165,583 · 1
Top collaborators
- Terence Marques Williams2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Leona W Ayers$17,539,894
- Susan R Mallery$15,292,540
- Deborah S. Parris$3,221,967
- Elliott D Crouser$4,838,276
- Arthur Roger Strauch$3,442,644
Others in their field
Top investigators on “Medical Outreach /Case Finding”
- Gregory H Reaman · National Childhood Cancer Foundation$123,104,101
- Norman Wolmark · Nsabp Foundation, Inc.$67,244,416
- Jeffrey P Krischer · University Of South Florida$38,040,597
- Craig M Wilson · University Of Alabama At Birmingham$18,996,867
- W. Archie Bleyer · National Childhood Cancer Foundation$18,804,557
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$16,145,568
Research focus
Medical Outreach /Case FindingPolymerase Chain ReactionHuman SubjectLymphomaNeoplasm /Cancer ImmunotherapyNonhodgkin'S LymphomaCytotoxic T LymphocyteFlow CytometryInterleukin 2Kaposi'S SarcomaMonoclonal AntibodyBiological Response ModifiersAids Related Neoplasm /CancerNeoplasm /Cancer PharmacologyCentral Nervous System NeoplasmsAids TherapyEpstein Barr VirusClinical ResearchClinical TrialsHuman Therapy EvaluationCooperative StudyCytokineCd95 MoleculePostoperative Complications
Grant awards (6)
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer$226,665
R01 · FY2020 · CA
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer$193,780
R01 · FY2020 · CA
Targeting RAF and VEGF Signaling in Thyroid Cancer$198,261
R21 · FY2006 · CA · contact PI
Targeting RAF and VEGF Signaling in Thyroid Cancer$201,514
R21 · FY2005 · CA
BIOLOGIC MODIFIER THERAPIES IN AIDS MALIGNANCIES$96,741
U01 · FY2004 · CA
BIOLOGIC MODIFIER THERAPIES IN AIDS MALIGNANCIES$68,842
U01 · FY2002 · CA